| 000 | 01216 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515174053.0 | ||
| 264 | 0 | _c20090902 | |
| 008 | 200909s 0 0 eng d | ||
| 022 | _a1873-5592 | ||
| 024 | 7 |
_a10.2174/138945009788488413 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBell, Brendan | |
| 245 | 0 | 0 |
_aDeciphering dual antiplatelet therapy in the era of drug-eluting coronary stents. _h[electronic resource] |
| 260 |
_bCurrent drug targets _cJun 2009 |
||
| 300 |
_a519-29 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCoronary Thrombosis _xprevention & control |
| 650 | 0 | 4 | _aDrug Hypersensitivity |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aDrug-Eluting Stents _xadverse effects |
| 650 | 0 | 4 |
_aGraft Occlusion, Vascular _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aWarfarin _xtherapeutic use |
| 700 | 1 | _aWalters, Darren | |
| 700 | 1 | _aSpaulding, Christian | |
| 773 | 0 |
_tCurrent drug targets _gvol. 10 _gno. 6 _gp. 519-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138945009788488413 _zAvailable from publisher's website |
| 999 |
_c18939084 _d18939084 |
||